Problem Statement: Cancer is a complex genetic disease. Evidence is emerging that particular microRNAs may play a role in human cancer pathogenesis; they exhibit important regulatory roles in development, cell proliferation, cell survival and apoptosis [1] . The effectiveness in treatment and curing cancer is directly dependent on the ability to detect cancers at their earlier stages. This study developed a neural network with back-propagation learning algorithm for the prediction of microRNAs responsible from cancer pathogenesis at earlier stages. Purpose of the Study: The aim of this research was to develop a nonlinear empirical model to predict a score value for specific microRNAs responsible from cancer pathogenesis by using micro-array data. Methods: The Back-Propagation Multi Layer perceptron (BPMLP) for the prediction of score value. The supervised learning algoritm is used during the training and testing stages. The number of inputs is fixed at two and the number of output is one. The 677 micro-array data were collected from a cancer microarray database and data-mining platform called Oncomine. Testing data are classified into randomly selected four groups of data. Findings and Results: In this work, a BPMLP, is used to establish the relationship between the microRNAs, p-value and score value. Accuracy rate was adjusted to 80 % and 90 %. The best performance was obtained with 20 neurons in the hidden layer and learning parameter as 0.00099. Conclusions and Recommendations: BPMLP is obtained by developing forward propagation phase and sensitivity network. It is shown that, the generalization capability can be significantly improved by optimizing some of the parameters such as learning parameter, and neuron number. Since microRNAs may play a role in human cancer pathogenesis, we have shown that, it is possible to predict relationships of microRNAs, p-values with different score values. Therefore, by using BPMLP, it is possible to predict microRNAs responsible from cancer pathogenesis at earlier stages.
Introduction
The early detection, diagnosis, and treatment of cancer are necessary before chemo-and/or radio-therapies and surgical operations. Circulating microRNAs as markers for cancer detection and monitoring could improve early diagnosis and reduce treatment costs and also mortality rate of the cancer [2] . MicroRNAs are small, non-coding, approximately 18-24 nts. A total of 10883 microRNAs have been identified and 721 microRNAs belong to Homo sapiens [3] . Our understanding of microRNAs has grown significantly in the last eight years. Many independent studies on different tissues demonstrated that cancer cells have different microRNA profiles compared with normal cells (Table I) . Recent works have shown that microRNA mutations correlate with various human cancers and indicate that microRNAs can function as tumor suppressors and oncogenes [4] [5] [6] [7] .
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Open access under CC BY-NC-ND license. Owing to the power of microRNAs in regulating several genes in post-transcriptional level they may be used in anticancer therapy and their profiles could be used for diagnosis. Today, technical developments allow us to measure the accumulation level of all known microRNAs using different approaches. The microarray, bead-based flow cytometry and quantitative PCR are some of these techniques. ONCOMINE is a cancer microarray database and web-based data-mining platform aimed at facilitating discovery from genome-wide expression analyses [8] . This study developed a neural network with back-propagation learning algorithm for the prediction of microRNAs responsible from cancer pathogenesis at earlier stages by using cancer microarray data from public ONCOMINE database. The aim of this research was to develop a nonlinear empirical model and to predict a score value for specific microRNAs responsible from cancer pathogenesis.
Methods
In this work, the Back-Propagation Multi Layer perceptron (BPMLP) for the prediction of score value is used. The architecture is the most commonly used multi-input single-output (MISO) system [9] . It consists of one input layer with M inputs, one output layer with one output and one hidden layers with varying number of nodes. The BPMLP neural network is a type of supervised, error correction learning that calculates an error on the output layer and propagates that error backwards through the network to determine how each individual weight factor contributes to the output error. The steepest-descent gradient approach used by the BPMLP to minimize the mean square error function and the local error function [9] defined as: where, d jp is the desired output signal of the jth output neuron for the pth example, n is the length of each example and y jp is the output signal. The total error function is defined as:
In this study, the number of inputs M was 2. The data from the input neurons is then propagated through the network via the interconnections such that every neuron in a layer is connected to every neuron in the adjacent layers. Where y j and . is the unipolar sigmoid activation function and u j is defined in equation 4 with its bias value j .
In addition to the weighted inputs to the neuron, a bias is included in order to shift the space of the nonlinearity. The second term in formula 5 is called the momentum term that makes the current (k-th) search directions. Momentum term enables the improvement of the convergence rate and the steady state performance of the backpropagation multi layer learning algorithm. In this work, the number of input neurons is fixed at two, number of hidden neurons is 20 and the number of output neuron is one. The 677 micro-array data were collected from a cancer microarray database and data-mining platform called Oncomine. Testing data are classified into randomly selected four groups of data.
Results and Discussions
A BPMLP, is used to establish the relationship between the microRNAs, p-value and score value. Accuracy rate was adjusted to 80 % and 90 %. The best performance was obtained with 20 neurons in the hidden layer and learning parameter as 0.00099.
The neural network was trained using randomly selected 50 data from the database in order to provide effective prediction of untrained data. Once the network converges (learns), this phase will only comprise generalizing the trained neural network using one forward pass.
The neural network consists of an input layer with 2 neurons, one hidden layer with 20 neurons which assures meaningful training while keeping the time cost to a minimum. The choice of 20 neurons in the hidden layer was a result of various training experiments. The output layer has only one neuron which yields normalized values (0 to 1) representing the score values. The activation function used for the processing neurons in the hidden and output layers is the sigmoid function. Throughout the learning phase, the learning coefficient and the momentum rate were adjusted several times in various experiments in order to achieve the required minimum error value of 0.002 which was considered as sufficient for this application after several experiments. The initial random weights for the first iteration were limited to a range of values between (−0.8 and 0.8). Table II lists the final parameters of the trained neural network. The training and testing set accuracies were listed on Table III . The total percent accuracy with level of significance (α) 72.5 % and 75 % with α=0.2. 
0 Conclusion and Recommendations
BPMLP is obtained by developing forward propagation phase and sensitivity network. It is shown that, the generalization capability can be significantly improved by optimizing some of the parameters such as learning rate, momentum rate and neuron number. Since microRNAs may play a role in human cancer pathogenesis, we have shown that, it is possible to predict relationships of microRNAs, p-values with different score values. Therefore, by using BPMLP, it is possible to predict microRNAs responsible from cancer pathogenesis at earlier stages.
